We are live on ! Find out more
CPRX

Catalyst Pharmaceutical
CPRX

Delisted

CPRX was delisted on the 14th of July, 2026.

Back to rankings

85 hedge funds and large institutions have $104M invested in Catalyst Pharmaceutical in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 18

6% less funds holding

Funds holding: 90 → 85 (-5)

23% less capital invested

Capital invested by funds: $134M → $104M (-$30.5M)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

77% less call options, than puts

Call options by funds: $3K | Put options by funds: $13K

Holders
85
Holders Change
-5
Holders Change %
-5.56%
% of All Funds
2.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
29
Reduced
18
Closed
14
Calls
$3K
Puts
$13K
Net Calls
-$10K
Net Calls Change
-$13K

Top Buyers

1
BBA
Baker Bros. Advisors
New York
+$2.69M
2
SFM
Sphera Funds Management
Israel
+$1.02M
3
Millennium Management
Millennium Management
New York
+$671K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$509K
5
State Street
State Street
Massachusetts
+$293K

Top Sellers

1
CCM
Consonance Capital Management
New York
-$8.35M
2
HM
HealthCor Management
New York
-$1.16M
3
TI
Turner Investments
Pennsylvania
-$1.1M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.1M
5
CCI
Columbus Circle Investors
-$419K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$629K – – –
KCM
27
Kennedy Capital Management
Missouri
$608K -$2.45K -854 -0.3%
Millennium Management
28
Millennium Management
New York
$607K +$671K +234,127 +1,709%
Citadel Advisors
29
Citadel Advisors
Florida
$437K +$104K +36,411 +26%
HCM
30
Highbridge Capital Management
New York
$358K +$287K +100,367 +221%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$342K +$7.14K +2,494 +2%
ERSOT
32
Employees Retirement System of Texas
Texas
$338K – – –
WMSA
33
Weiss Multi-Strategy Advisers
New York
$299K – – –
TA
34
Teachers Advisors
New York
$271K – – –
Charles Schwab
35
Charles Schwab
California
$263K – – –
TCM
36
Tanaka Capital Management
New York
$237K – – –
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$184K +$19.2K +6,710 +10%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$169K – – –
AQR Capital Management
39
AQR Capital Management
Connecticut
$156K -$217K -75,820 -54%
CS
40
Credit Suisse
Switzerland
$137K +$62.3K +21,741 +63%
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$136K +$23.5K +8,218 +17%
NFA
42
Nationwide Fund Advisors
Ohio
$119K – – –
AIG
43
American International Group
New York
$108K -$221 -77 -0.2%
QSS
44
Quantitative Systematic Strategies
Florida
$105K +$119K +41,502 New
VOYA Investment Management
45
VOYA Investment Management
Georgia
$104K – – –
IT
46
Independence Trust
Tennessee
$103K +$40.1K +14,000 +50%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$101K – – –
BFM
48
Boothbay Fund Management
New York
$97K -$68.7K -23,972 -38%
AL
49
Agran Libbie
California
$87K – – –
SCA
50
Secor Capital Advisors
New York
$83K -$15.9K -5,567 -14%
1
2
3 4

CPRX Hedge Fund Activity: Q4 2015 in Review

85 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Catalyst Pharmaceutical (CPRX) for Q4 2015, worth a combined $104M — down 23% from $134M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CPRX and 9 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 29 added.

The largest buyer was Baker Bros. Advisors, adding an estimated $2.69M. The largest seller was Consonance Capital Management, cutting an estimated $8.35M.

  • 85 institutional investors held Catalyst Pharmaceutical (CPRX) as of Q4 2015, down from 90 in Q3 2015.
  • Funds reported $104M of Catalyst Pharmaceutical stock for Q4 2015, down 23% quarter-over-quarter.
  • 9 funds opened new Catalyst Pharmaceutical positions in Q4 2015 and 14 closed out, a net change of -5 holders.
  • The largest Catalyst Pharmaceutical buyer in Q4 2015 was Baker Bros. Advisors, an estimated $2.69M added.
  • The largest Catalyst Pharmaceutical seller in Q4 2015 was Consonance Capital Management, an estimated $8.35M sold.

Based on aggregated 13F filings for Q4 2015.